ROSUVASTATIN 10mg. IP

A potent lipid-lowering medication that reduces the amount of cholesterol made by the liver. Corrects the levels of fatty substances, and aids stop blockages from forming in arteries. Produces substantial reductions in low-density lipoprotein cholesterol. A promising new medication for the treatment of dyslipidemias. (Olsson, 24) A valuable addition to the statin drug class. (Cheng-Lai, 2003) Facilitates efficient management of patients with dyslipidemia. (Kathleen M Fox, 2007) A well-tolerated and effective drug that exerts a good safety profile in hypercholesterolemic patients. (Charles J Glueck, 2006) Lessens the risk of cardiovascular events and stabilizes atherosclerosis. (Toth, 2014) Represents a three-fold greater potency at decreasing low-density lipoprotein-cholesterol than atorvastatin. (Stephen P Adams, 2014) More efficacious in improving the lipid profile of patients with hypercholesterolemia than atorvastatin, simvastatin, and pravastatin. (Peter H Jones, 2004) An effective treatment for reducing low-density lipoprotein cholesterol levels than the other statins in a population of elderly patients. (Carolyn R Harley, 2007) Lowers the risk of cardiovascular disease and coronary events like heart attack, stroke, and heart-related chest pain. More efficacious than atorvastatin in modifying lipids in patients with hypercholesterolemia and a high coronary heart disease risk. (Gregory G Schwartz, 2004)